In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.4 | 0.0 |
Revenue growth | | -100.0% | | | | -100.0% | 1069.4% | |
Cost of goods sold | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 |
Gross margin | | | 0.0% | | | | 75.3% | 29.7% |
Selling, general and administrative [+] | 2.1 | 0.4 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 |
Sales and marketing | | | | | 0.0 | 0.0 | 0.0 | |
General and administrative [+] | 2.1 | 0.4 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 |
General and administrative expenses | 1.8 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 |
Professional fees | 0.3 | 0.3 | | | | | | 0.0 |
Research and development | | | | 0.0 | 0.3 | 0.5 | 0.1 | |
Other operating expenses | 0.0 | | 0.1 | 0.4 | 1.5 | 0.6 | 0.2 | |
EBITDA [+] | -2.1 | -0.4 | | -0.6 | -1.9 | -1.2 | | |
EBITDA growth | 443.5% | 107.8% | -68.2% | -69.9% | 60.7% | 551.7% | 233.2% | |
EBITDA margin | | | -100.0% | | | | -53.0% | -185.9% |
Depreciation and amortization | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | | |
EBIT [+] | -2.1 | -0.4 | -0.2 | -0.6 | -1.9 | -1.2 | -0.2 | -0.1 |
EBIT growth | 445.0% | 108.1% | -68.2% | -69.9% | 60.6% | 552.4% | 233.2% | |
EBIT margin | | | -100.0% | | | | -53.0% | -185.9% |
Non-recurring items [+] | | | | | -0.4 | | | |
Asset impairment | | | | | -0.2 | | | |
Legal settlement | | | | | -0.3 | | | |
Interest expense | 1.0 | 0.0 | 0.8 | 0.6 | 0.4 | 0.1 | | |
Interest expense | 1.0 | 0.0 | 0.8 | 0.6 | 0.4 | 0.1 | | |
Other income (expense), net [+] | -1.0 | | -0.1 | -0.2 | -1.3 | 0.2 | | |
Gain (loss) on debt retirement | | | | | -0.7 | | | |
Gain (loss) on derivative instruments | 0.7 | | -0.1 | | | | | |
Other | | | -1.0 | -0.8 | -1.8 | 0.1 | | |
Pre-tax income | -4.1 | -0.4 | -1.1 | -1.4 | -3.3 | -1.1 | -0.2 | -0.1 |
Income taxes | 0.0 | 1.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | | 0.0% | 0.0% | 0.0% | 0.0% | | |
Earnings from continuing ops | -4.2 | -2.8 | -1.1 | -1.4 | -3.3 | -1.1 | -0.2 | -0.1 |
Earnings from discontinued ops | | 0.6 | | | | | | |
Net income | -4.2 | -2.2 | -1.1 | -1.4 | -3.3 | -1.1 | -0.2 | -0.1 |
Net margin | | | -615.5% | | | | -53.1% | -187.5% |
|
Basic EPS [+] | ($1.73) | ($1.18) | ($0.12) | ($0.26) | ($1.51) | ($0.39) | $0.00 | $0.00 |
Growth | 46.9% | 885.0% | -54.9% | -82.5% | 285.1% | 17019.0% | 172.1% | |
Diluted EPS [+] | ($1.73) | ($1.18) | ($0.12) | ($0.26) | ($1.51) | ($0.39) | $0.00 | $0.00 |
Growth | 46.9% | 885.0% | -54.9% | -82.5% | 285.1% | 17019.0% | 172.1% | |
|
Shares outstanding (basic) [+] | 2.4 | 2.4 | 9.6 | 5.3 | 2.2 | 2.8 | 81.1 | 66.6 |
Growth | 0.0% | -74.8% | 82.4% | 142.9% | -22.0% | -96.6% | 21.7% | |
Shares outstanding (diluted) [+] | 2.4 | 2.4 | 9.6 | 5.3 | 2.2 | 2.8 | 81.1 | 66.6 |
Growth | 0.0% | -74.8% | 82.4% | 142.9% | -22.0% | -96.6% | 21.7% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |